NCT01719432View on ClinicalTrials.gov

Effect of Body Mass on Filgrastim Pharmacokinetics

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 5, 2012

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Hematological MalignancyNeutropenia
Trial Locations (1)

26506

West Virginia University Mary Babb Randolph Cancer Center, Morgantown

All Listed Sponsors
lead

Aaron Cumpston, PharmD, BCOP

OTHER

NCT01719432 - Effect of Body Mass on Filgrastim Pharmacokinetics | Biotech Hunter | Biotech Hunter